Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Clarithromycin - Generic Drug Details

« Back to Dashboard

What are the generic sources for clarithromycin and what is the scope of clarithromycin patent protection?

Clarithromycin
is the generic ingredient in three branded drugs marketed by Ranbaxy, Allied Pharma Inc, Lupin Ltd, Sandoz, Ivax Sub Teva Pharms, Actavis Labs Fl Inc, Idt Australia Ltd, Mayne Pharma, Teva, Abbvie, Wockhardt, Sun Pharm Inds Ltd, West-ward Pharms Int, Apotex Corp, Hec Pharm Usa Inc, Aurobindo, and Mylan, and is included in twenty-three NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Clarithromycin has fifty-seven patent family members in twenty-nine countries.

There are twenty-one drug master file entries for clarithromycin. Forty-four suppliers are listed for this compound.

Summary for Generic Name: clarithromycin

Tradenames:3
Patents:3
Applicants:17
NDAs:23
Drug Master File Entries: see list21
Suppliers / Packagers: see list44
Bulk Api Vendors: see list34
Clinical Trials: see list85
Patent Applications: see list6,750
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:clarithromycin at DailyMed

Pharmacology for Ingredient: clarithromycin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz
CLARITHROMYCIN
clarithromycin
FOR SUSPENSION;ORAL065283-002Sep 4, 2007ABRXNoNo► Subscribe► Subscribe
Wockhardt
CLARITHROMYCIN
clarithromycin
TABLET;ORAL065266-002May 31, 2006ABRXNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
CLARITHROMYCIN
clarithromycin
FOR SUSPENSION;ORAL065382-002Aug 30, 2007ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
CLARITHROMYCIN
clarithromycin
TABLET, EXTENDED RELEASE;ORAL202532-001Sep 15, 2015ABRXNoNo► Subscribe► Subscribe
Abbvie
BIAXIN XL
clarithromycin
TABLET, EXTENDED RELEASE;ORAL050775-001Mar 3, 2000DISCNYesNo6,010,718► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot